Skip to main navigation Skip to search Skip to main content

Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Search results